Natural Alternatives International (NAII) 10-Q 14 Feb 17 2017 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2016	Feb. 10, 2017
Document Information [Line Items]
Entity Registrant Name	NATURAL ALTERNATIVES INTERNATIONAL INC
Entity Central Index Key	787,253
Trading Symbol	naii
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		6,872,224
Document Type	10-Q
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Current assets:
Cash and cash equivalents	$ 21,362	$ 19,747
Accounts receivable - less allowance for doubtful accounts of $15 at December 31, 2016 and $45 at June 30, 2016	9,838	13,217
Inventories, net	17,067	20,768
Income tax receivable	14	14
Prepaids and other current assets	3,985	2,136
Total current assets	52,266	55,882
Property and equipment, net	17,469	15,167
Deferred income taxes	2,227	2,227
Other noncurrent assets, net	832	899
Total assets	72,794	74,175
Current liabilities:
Accounts payable	6,291	12,821
Accrued liabilities	2,021	2,242
Accrued compensation and employee benefits	1,076	2,802
Income taxes payable	2,076	1,340
Total current liabilities	11,464	19,205
Other noncurrent liabilities, net	858	758
Deferred rent	516	486
Total liabilities	12,838	20,449
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding	0	0
Common stock; $.01 par value; 20,000,000 shares authorized; issued and outstanding (net of treasury shares) 6,872,224 at December 31, 2016 and 6,868,628 at June 30, 2016	77	77
Additional paid-in capital	21,644	21,138
Accumulated other comprehensive (loss)	172	(680)
Retained earnings	43,509	38,553
Treasury stock, at cost, 964,453 shares at December 31, 2016 and 958,049 June 30, 2016	(5,446)	(5,362)
Total stockholders’ equity	59,956	53,726
Total liabilities and stockholders’ equity	$ 72,794	$ 74,175

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Accounts receivable, allowance for doubtful accounts	$ 15	$ 45
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, issued (in shares)	6,872,224	6,868,628
Common stock, outstanding (in shares)	6,872,224	6,868,628
Treasury stock, shares (in shares)	964,453	958,049

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Net sales	$ 30,559	$ 26,911	$ 64,626	$ 48,496
Cost of goods sold	24,064	21,242	50,462	38,094
Gross profit	6,495	5,669	14,164	10,402
Selling, general and administrative	3,382	2,934	7,515	5,939
Income from operations	3,113	2,735	6,649	4,463
Other income (expense):
Interest income	133	25	249	56
Interest expense		(2)		(3)
Foreign exchange gain (loss)	262	(96)	203	(104)
Other, net	(8)	(2)	(15)	(10)
Total other income (expense)	387	(75)	437	(61)
Income before income taxes	3,500	2,660	7,086	4,402
Provision for income taxes	1,034	792	2,130	1,321
Net income	2,466	1,868	4,956	3,081
Unrealized gain resulting from change in fair value of derivative instruments, net of tax	1,242	230	852	274
Comprehensive income	$ 3,708	$ 2,098	$ 5,808	$ 3,355
Net income per common share:
Basic (in dollars per share)	$ 0.38	$ 0.29	$ 0.76	$ 0.47
Diluted (in dollars per share)	$ 0.37	$ 0.28	$ 0.74	$ 0.46
Weighted average common shares outstanding
Basic (in shares)	6,567,468	6,509,893	6,562,932	6,515,280
Diluted (in shares)	6,683,356	6,628,752	6,665,159	6,662,036

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities
Net Income	$ 4,956	$ 3,081
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,059	944
Non-cash compensation	506	280
Pension expense	100	25
(Gain) loss on disposal of assets	(23)	(232)
Changes in operating assets and liabilities:
Accounts receivable, net	3,379	2,322
Inventories, net	3,701	(5,657)
Prepaids and other assets	(449)	880
Accounts payable and accrued liabilities	(6,721)	2,078
Income taxes	255	1,262
Accrued compensation and employee benefits	(1,726)	146
Net cash provided by operating activities	5,037	5,129
Cash flows from investing activities
Purchases of property and equipment	(3,362)	(1,410)
Proceeds from sale of property and equipment	24	568
Net cash used in investing activities	(3,338)	(842)
Cash flows from financing activities
Repurchase of common stock	(84)	(212)
Net cash used in financing activities	(84)	(212)
Net increase in cash and cash equivalents	1,615	4,075
Cash and cash equivalents at beginning of period	19,747	18,551
Cash and cash equivalents at end of period	21,362	22,626
Supplemental disclosures of cash flow information
Interest
Taxes	1,897	468
Disclosure of non-cash activities:
Change in unrealized gain resulting from change in fair value of derivative instruments, net of tax	$ 852	$ 274

Note A - Basis of Presentation

Note A - Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	A. Basis of Presentation and Summary of Significant Accounting Policies The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10 three six December 31, 2016 You should read the financial statements and these notes, which are an integral part of the financial statements, together with our audited financial statements included in our Annual Report on Form 10 June 30, 2016 (“2016 2016 Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2016 2015 2016 2015 Numerator Net Income $ 2,466 $ 1,868 $ 4,956 $ 3,081 Denominator Basic weighted average common shares outstanding 6,567 6,510 6,563 6,515 Dilutive effect of stock options 116 119 102 147 Diluted weighted average common shares outstanding 6,683 6,629 6,665 6,662 Basic net income per common share $ 0.38 $ 0.29 $ 0.76 $ 0.47 Diluted net income per common share $ 0.37 $ 0.28 $ 0.74 $ 0.46 No three six December 31, 2016. ded shares related to stock options totaling 100,000 three six December 31, 2015 Revenue Recognition To recognize revenue, four 1) 2) 3) 4) uyer has the right to return the product is recognized at the time of sale only if (a) the seller’s price to the buyer is substantially fixed or determinable at the date of sale; (b) the buyer has paid the seller, or the buyer is obligated to pay the seller and the obligation is not contingent on resale of the product; (c) the buyer’s obligation to the seller would not be changed in the event of theft or physical destruction or damage of the product; (d) the buyer acquiring the product for resale has economic substance apart from that provided by the seller; (e) the seller does not have significant obligations for future performance to directly bring about resale of the product by the buyer; and (f) the amount of future returns can be reasonably estimated. We recognize revenue upon determination that all criteria for revenue recognition have been met. The criteria are usually met at the time title passes to the customer, which usually occurs upon shipment. Revenue from shipments where title passes upon delivery is deferred until the shipment has been delivered. We record reductions to gross revenue for estimated returns of private-label contract manufacturing products and beta-alanine raw material sales. The estimated returns are based on the trailing six nths of private-label contract manufacturing gross sales and our historical experience for both private-label contract manufacturing and beta-alanine raw material product returns. However, the estimate for product returns does not reflect the impact of a potential large product recall resulting from product nonconformance or other factors as such events are not predictable nor is the related economic impact estimable. We currently own certain U.S. patents, and each patent ’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine marketed and sold under the CarnoSyn® and SR CarnoSyn® trademarks. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $6.7 three December 31, 2016 $13.4 six December 31, 2016. $5.3 three December 31, 2015 $10.6 six December 31, 2015. $250,000 three December 31, 2016 $566,000 six December 31, 2016. $209,000 three December 31, 2015 $473,000 six December 31, 2015. Stock-Based Compensation We have an omnibus incentive plan that was approved by our Board of Directors effective as of October 15, 2009 November 30, 2009. may We estimate the fair value of stock option awards at the date of grant using the Black-Schole s option valuation model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Option valuation models require the input of highly subjective assumptions. Black-Scholes uses assumptions related to volatility, the risk-free interest rate, the dividend yield (which we assume to be zero, The Company did not ns during the three six December 31, 2016 2015. No three six December 31, 2016 2015. Our net income included stock based c ompensation expense of approximately $256,000 three December 31, 2016, $506,000 six December 31, 2016. $150,000 three December 31, 2015, $280,000 six December 31, 2015. Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (i.e., the “ exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We use a three The fair value hierarchy is broken down into three 1 1 2 3 As of December 31, 2016 June 30, 2016, not 1. 2 December 31, 2016 $2.0 June 30, 2016 $250,000. December 31, 2016 June 30, 2016 not 3. r any assets or liabilities between Levels during fiscal 2016 six December 31, 2016.

Note B - Inventories, Net

Note B - Inventories, Net	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Inventory Disclosure [Text Block]	B. Inventories, net Inventories, net consisted of the following (in thousands): December 31, 2016 June 30, 2016 Raw materials $ 11,475 $ 14,751 Work in progress 2,096 3,487 Finished goods 3,836 2,832 Reserves (340 ) (302 ) Inventories, net $ 17,067 $ 20,768

Note C - Property and Equipment

Note C - Property and Equipment	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	C. Property and Equipment Property and equipment consisted of the following (in thousands): Depreciable Life In Years December 31, 2016 June 30, 2016 Land N/A $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,616 3,324 Machinery and equipment 3 – 12 24,772 23,846 Office equipment and furniture 3 – 5 3,577 2,994 Vehicles 3 3 209 209 Leasehold improvements 1 – 15 16,432 15,261 Total property and equipment 49,806 46,834 Less: accumulated depreciation and amortization (32,337 ) (31,667 ) Property and equipment, net $ 17,469 $ 15,167

Note D - Accumulated Other Comp

Note D - Accumulated Other Comprehensive (Loss) Income	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	D. Accumulated Other Comprehensive (Loss) Income Accumulated other comprehensive (loss) income consisted of the following during the three six December 31, 2016 December 31, 2015 Three Months Ended Six Months Ended December 31, 2016 December 31, 2016 Defined Unrealized Defined Unrealized Benefit Gains on Benefit Gains on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning balance $ (775 ) $ (295 ) $ (1,070 ) $ (775 ) $ 95 $ (680 ) OCI/OCL before reclassifications - 2,287 2,287 - 1,834 1,834 Amounts reclassified from OCI - (343 ) (343 ) - (501 ) (501 ) Tax effect of OCI activity - (702 ) (702 ) - (481 ) (481 ) Net current period OCI/OCL - 1,242 1,242 - 852 852 Ending balance $ (775 ) $ 947 $ 172 $ (775 ) $ 947 $ 172 Three Months Ended Six Months Ended December 31, 2015 December 31, 2015 Defined Unrealized Defined Unrealized Benefit Gains on Benefit Gains on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning balance $ (643 ) $ (79 ) $ (722 ) $ (643 ) $ (123 ) $ (766 ) OCI/OCL before reclassifications - 424 424 - 482 482 Amounts reclassified from OCI - (69 ) (69 ) - (58 ) (58 ) Tax effect of OCI activity - (125 ) (125 ) - (150 ) (150 ) Net current period OCI/OCL - 230 230 - 274 274 Ending balance $ (643 ) $ 151 $ (492 ) $ (643 ) $ 151 $ (492 ) During the three December 31, 2016, ified from OCI were comprised of $213,000 $130,000 six December 31, 2016, $271,000 $230,000 During the three December 31, 2015, $45,0 00 $24,000 six December 31, 2015, $7,000 $51,000

Note E - Debt

Note E - Debt	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Debt Disclosure [Text Block]	E. Debt On February 1, 2016, y and increased our credit line from $5.0 $10.0 may no no Under the terms of the Credit Agreement, borrowings are subject to eligibility requirements including maintaining (i) a ratio of total liabilities to tangible net worth of not greater than 1.25 1.0 to total current liabilities of not less than 1.75 1.0 $100,000 1.25% one 1.25% first January 31, 2019. may may $100,000, Our obligations under the Credit Agreement are secured by our accounts receivable and other rights to payment, general intangibles, inventory, equipment and fixtures. We also have a foreign exchange facility with Wells Fargo Bank, N.A. in effect until January 31, 2019, August 15, 2017. On December 31, 2016, Our wholly owned subsidiary, NAIE, formerly had a credit facility with Credit Suisse that would provide NAIE w ith a credit line of up to CHF 500,000, $488,000. December 2016 We did not nor six December 31, 2016. December 31, 2016, $10.0

Note F - Economic Dependency

Note F - Economic Dependency	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	F. Economic Dependency We had substantial net sales to certain customers during the periods shown in the following table. The loss of any of these customers, or a significant decline in sales to these customers, the growth rate of sales to these c ustomers, or in these customers’ ability to make payments when due, could have a material adverse impact on our net sales and net income. Net sales to any one 10% Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Customer 1 $ 15,074 $ 11,902 $ 32,152 $ 18,691 Customer 2 (a) 3,304 (a) 6,339 $ 15,074 $ 15,206 $ 32,152 $ 25,030 (a) Sales were less than 10% We buy certain products, including beta-alanine, from a limited number of raw material suppliers. The loss of any of these suppliers could have a material adverse impact on our net sales and net income. Raw material purchases from any one 10% Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Supplier 1 (a) (a) (a) $ 3,097 12% Supplier 2 (a) $ 1,395 12% (a) (a) $ - $ 1,395 12% $ - $ 3,097 12% (a) Purchases were less than 10% ’s total raw material purchases.

Note G - Segment Information

Note G - Segment Information	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	G. Segment Information Our business consists of two te nutritional supplements and other health care products; and (ii) patent and trademark licensing, which primarily includes direct raw material sales and royalty income from our license and supply agreements associated with the sale and use of beta-alanine under our CarnoSyn® trade name. We evaluate performance based on a number of factors. The primary performance measures for each segment are net sales and income or loss from operations before corporate allocations. Operating income or loss for each segm ent does not include corporate general and administrative expenses, interest expense and other miscellaneous income and expense items. Corporate general and administrative expenses include, but are not limited to: human resources, corporate legal, finance, information technology, and other corporate level related expenses, which are not allocated to any segment. The accounting policies of our segments are the same as those described in Note A above and in the consolidated financial statements included in our 2016 Our operating results by business segment were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Net Sales Private label contract manufacturing $ 23,864 $ 21,619 $ 51,243 $ 37,884 Patent and trademark licensing 6,695 5,292 13,383 10,612 Total Net Sales $ 30,559 $ 26,911 $ 64,626 $ 48,496 Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Income from Operations Private label contract manufacturing $ 2,148 $ 2,543 $ 5,462 $ 4,603 Patent and trademark licensing 2,340 1,692 4,240 2,691 Income from operations of reportable segments 4,488 4,235 9,702 7,294 Corporate expenses not allocated to segments (1,375 ) (1,500 ) (3,053 ) (2,831 ) Total Income from Operations $ 3,113 $ 2,735 $ 6,649 $ 4,463 Total Assets December 31, 20 16 June 30, 2016 Private label contract manufacturing $ 62,742 $ 66,375 Patent and Trademark Licensing 10,052 7,800 Total $ 72,794 $ 74,175 Our private label contract manufacturing products are sold both in the U.S. and in markets outside the U.S., including Europe, Australia, Asia, Canada, Mexico and South Africa. Our primary market outside the U.S. is Europe. Our patent and trademark licensi ng activities are primarily based in the U.S. Net sales by geographic region, based on the customers ’ location, were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 United States $ 13,654 $ 12,498 $ 28,879 $ 25,291 Markets outside of the United States 16,905 14,413 35,747 23,205 Total $ 30,559 $ 26,911 $ 64,626 $ 48,496 Products manufactured by NAIE accounted for 60% three December 31, 2016, 53% six December 31, 2016. 71% ets outside the U.S. for the three December 31, 2015, 74% six December 31, 2015. No three six December 31, 2016 2015. Assets and capit al expenditures by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Long-Lived Assets Total Assets Capital Expenditures Six Months Ended December 31, 2016 June 30, 2016 December 31, 2016 June 30, 2016 December 31, 2016 December 31, 2015 United States $ 10,897 $ 9,678 $ 46,424 $ 49,755 $ 1,812 $ 320 Europe 6,572 5,489 26,370 24,420 1,550 1,090 $ 17,469 $ 15,167 $ 72,794 $ 74,175 $ 3,362 $ 1,410

Note H - Income Taxes

Note H - Income Taxes	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Income Tax Disclosure [Text Block]	H. Income Taxes The effective tax rate for the three December 31, 2016 29.6% six December 31, 2016 30.1%. 34% f foreign earnings taxed at less than the U.S. statutory rate. To determine our quarterly provision for income taxes, we use an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportuniti es available in the various jurisdictions to which we are subject. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rate from quarter to quarter. There were no discrete items for the six December 31, 2016. We record valuation allowances to reduce our deferred tax assets to an amount th at we believe is more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. During the six December 31, 2016, Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates, for each of the jurisdictions in which we operate, expected to apply to taxable income in the years in which tho se temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We are subject to taxation in the U.S., Swi tzerland and various state jurisdictions. Our tax years for the fiscal year ended June 30, 2013 June 30, 2008 June 30, 2015 We do not record U.S. income tax expense for NAIE ’s retained earnings that are declared as indefinitely reinvested offshore, thus reducing our overall income tax expense. The amount of earnings designated as indefinitely reinvested in NAIE is based on the actual deployment of such earnings in NAIE’s assets and our expectations of the future cash needs of our U.S. and foreign entities. Currently income tax laws are also a factor in determining the amount of foreign earnings to be indefinitely reinvested offshore. It is our policy to establish reserves based on management ’s assessment of exposure for certain positions taken in previously filed tax returns that may six December 31, 2016.

Note I - Treasury Stock

Note I - Treasury Stock	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Treasury Stock [Text Block]	I. Treasury Stock On June 2, 2011, $2.0 February 6, 2015, $1.0 $3.0 May 11, 2015, $2.0 $5.0 may, may During the six December 31, 2016, chase any shares under this repurchase plan. During the six December, 2015, 35,703 $5.91 $212,000

Note J - Derivatives and Hedgin

Note J - Derivatives and Hedging	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	J. Derivatives and Hedging We are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates relating to forecasted product sales denominated in foreign currencies and transactions of NAIE, our foreign subsidiary. As part of our overall st rategy to manage the level of exposure to the risk of fluctuations in foreign currency exchange rates, we may As of December 31, 2016, ucts at prices denominated in currencies other than the U.S. Dollar. These contracts are expected to be settled through February 2018. For foreign currency contracts designated as cash flow hedges, hedge effectiveness is measured using the spot rate. Changes in the spot-forward differential are excluded from the test of hedge effectiveness and are recorded currently in earnings as in terest expense or income. We measure effectiveness by comparing the cumulative change in the hedge contract with the cumulative change in the hedged item. During the three six December 31, 2016, $92,000 three six December 31, 2015. As of December 31, 2016, $35.2 31.1 December 31, 2016, $1.5 truments designated as cash flow hedges was recorded in OCI. It is expected that $1.3 12 As of December 31, 2016, value of our cash flow hedges was an asset of $2.0 three December 31, 2016, $2.3 $213,000 six December 31, 2016, $1.8 $271,000 June 30, 2016, $226,000 three December 31, 2015, $424,000 $45,000 six December 31, 2015, $482,000 $7,000

Note K - Contingencies

Note K - Contingencies	6 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	K. Contingencies From time to time, we become involved in various investigations, claims and legal proceedings that arise in the ordinary course of our business. These matters may

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Earnings Per Share, Policy [Policy Text Block]	Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 2016 2015 2016 2015 Numerator Net Income $ 2,466 $ 1,868 $ 4,956 $ 3,081 Denominator Basic weighted average common shares outstanding 6,567 6,510 6,563 6,515 Dilutive effect of stock options 116 119 102 147 Diluted weighted average common shares outstanding 6,683 6,629 6,665 6,662 Basic net income per common share $ 0.38 $ 0.29 $ 0.76 $ 0.47 Diluted net income per common share $ 0.37 $ 0.28 $ 0.74 $ 0.46 No three six December 31, 2016. ded shares related to stock options totaling 100,000 three six December 31, 2015
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition To recognize revenue, four 1) 2) 3) 4) uyer has the right to return the product is recognized at the time of sale only if (a) the seller’s price to the buyer is substantially fixed or determinable at the date of sale; (b) the buyer has paid the seller, or the buyer is obligated to pay the seller and the obligation is not contingent on resale of the product; (c) the buyer’s obligation to the seller would not be changed in the event of theft or physical destruction or damage of the product; (d) the buyer acquiring the product for resale has economic substance apart from that provided by the seller; (e) the seller does not have significant obligations for future performance to directly bring about resale of the product by the buyer; and (f) the amount of future returns can be reasonably estimated. We recognize revenue upon determination that all criteria for revenue recognition have been met. The criteria are usually met at the time title passes to the customer, which usually occurs upon shipment. Revenue from shipments where title passes upon delivery is deferred until the shipment has been delivered. We record reductions to gross revenue for estimated returns of private-label contract manufacturing products and beta-alanine raw material sales. The estimated returns are based on the trailing six nths of private-label contract manufacturing gross sales and our historical experience for both private-label contract manufacturing and beta-alanine raw material product returns. However, the estimate for product returns does not reflect the impact of a potential large product recall resulting from product nonconformance or other factors as such events are not predictable nor is the related economic impact estimable. We currently own certain U.S. patents, and each patent ’s corresponding foreign patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine marketed and sold under the CarnoSyn® and SR CarnoSyn® trademarks. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $6.7 three December 31, 2016 $13.4 six December 31, 2016. $5.3 three December 31, 2015 $10.6 six December 31, 2015. $250,000 three December 31, 2016 $566,000 six December 31, 2016. $209,000 three December 31, 2015 $473,000 six December 31, 2015.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation We have an omnibus incentive plan that was approved by our Board of Directors effective as of October 15, 2009 November 30, 2009. may We estimate the fair value of stock option awards at the date of grant using the Black-Schole s option valuation model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Option valuation models require the input of highly subjective assumptions. Black-Scholes uses assumptions related to volatility, the risk-free interest rate, the dividend yield (which we assume to be zero, The Company did not ns during the three six December 31, 2016 2015. No three six December 31, 2016 2015. Our net income included stock based c ompensation expense of approximately $256,000 three December 31, 2016, $506,000 six December 31, 2016. $150,000 three December 31, 2015, $280,000 six December 31, 2015.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (i.e., the “ exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We use a three The fair value hierarchy is broken down into three 1 1 2 3 As of December 31, 2016 June 30, 2016, not 1. 2 December 31, 2016 $2.0 June 30, 2016 $250,000. December 31, 2016 June 30, 2016 not 3. r any assets or liabilities between Levels during fiscal 2016 six December 31, 2016.

Note A - Basis of Presentatio18

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Six Months Ended December 31, December 31, 2016 2015 2016 2015 Numerator Net Income $ 2,466 $ 1,868 $ 4,956 $ 3,081 Denominator Basic weighted average common shares outstanding 6,567 6,510 6,563 6,515 Dilutive effect of stock options 116 119 102 147 Diluted weighted average common shares outstanding 6,683 6,629 6,665 6,662 Basic net income per common share $ 0.38 $ 0.29 $ 0.76 $ 0.47 Diluted net income per common share $ 0.37 $ 0.28 $ 0.74 $ 0.46

Note B - Inventories, Net (Tabl

Note B - Inventories, Net (Tables)	6 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2016 June 30, 2016 Raw materials $ 11,475 $ 14,751 Work in progress 2,096 3,487 Finished goods 3,836 2,832 Reserves (340 ) (302 ) Inventories, net $ 17,067 $ 20,768

Note C - Property and Equipme20

Note C - Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2016
Notes Tables
Property, Plant and Equipment [Table Text Block]	Depreciable Life In Years December 31, 2016 June 30, 2016 Land N/A $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,616 3,324 Machinery and equipment 3 – 12 24,772 23,846 Office equipment and furniture 3 – 5 3,577 2,994 Vehicles 3 3 209 209 Leasehold improvements 1 – 15 16,432 15,261 Total property and equipment 49,806 46,834 Less: accumulated depreciation and amortization (32,337 ) (31,667 ) Property and equipment, net $ 17,469 $ 15,167

Note D - Accumulated Other Co21

Note D - Accumulated Other Comprehensive (Loss) Income (Tables)	6 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Three Months Ended Six Months Ended December 31, 2016 December 31, 2016 Defined Unrealized Defined Unrealized Benefit Gains on Benefit Gains on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning balance $ (775 ) $ (295 ) $ (1,070 ) $ (775 ) $ 95 $ (680 ) OCI/OCL before reclassifications - 2,287 2,287 - 1,834 1,834 Amounts reclassified from OCI - (343 ) (343 ) - (501 ) (501 ) Tax effect of OCI activity - (702 ) (702 ) - (481 ) (481 ) Net current period OCI/OCL - 1,242 1,242 - 852 852 Ending balance $ (775 ) $ 947 $ 172 $ (775 ) $ 947 $ 172 Three Months Ended Six Months Ended December 31, 2015 December 31, 2015 Defined Unrealized Defined Unrealized Benefit Gains on Benefit Gains on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning balance $ (643 ) $ (79 ) $ (722 ) $ (643 ) $ (123 ) $ (766 ) OCI/OCL before reclassifications - 424 424 - 482 482 Amounts reclassified from OCI - (69 ) (69 ) - (58 ) (58 ) Tax effect of OCI activity - (125 ) (125 ) - (150 ) (150 ) Net current period OCI/OCL - 230 230 - 274 274 Ending balance $ (643 ) $ 151 $ (492 ) $ (643 ) $ 151 $ (492 )

Note F - Economic Dependency (T

Note F - Economic Dependency (Tables)	6 Months Ended
	Dec. 31, 2016
Supplier Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Supplier 1 (a) (a) (a) $ 3,097 12% Supplier 2 (a) $ 1,395 12% (a) (a) $ - $ 1,395 12% $ - $ 3,097 12%
Customer Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Customer 1 $ 15,074 $ 11,902 $ 32,152 $ 18,691 Customer 2 (a) 3,304 (a) 6,339 $ 15,074 $ 15,206 $ 32,152 $ 25,030

Note G - Segment Information (T

Note G - Segment Information (Tables)	6 Months Ended
	Dec. 31, 2016
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Net Sales Private label contract manufacturing $ 23,864 $ 21,619 $ 51,243 $ 37,884 Patent and trademark licensing 6,695 5,292 13,383 10,612 Total Net Sales $ 30,559 $ 26,911 $ 64,626 $ 48,496 Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 Income from Operations Private label contract manufacturing $ 2,148 $ 2,543 $ 5,462 $ 4,603 Patent and trademark licensing 2,340 1,692 4,240 2,691 Income from operations of reportable segments 4,488 4,235 9,702 7,294 Corporate expenses not allocated to segments (1,375 ) (1,500 ) (3,053 ) (2,831 ) Total Income from Operations $ 3,113 $ 2,735 $ 6,649 $ 4,463
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Total Assets December 31, 20 16 June 30, 2016 Private label contract manufacturing $ 62,742 $ 66,375 Patent and Trademark Licensing 10,052 7,800 Total $ 72,794 $ 74,175
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2016 2015 2016 2015 United States $ 13,654 $ 12,498 $ 28,879 $ 25,291 Markets outside of the United States 16,905 14,413 35,747 23,205 Total $ 30,559 $ 26,911 $ 64,626 $ 48,496
Long-lived Assets by Geographic Areas [Table Text Block]	Long-Lived Assets Total Assets Capital Expenditures Six Months Ended December 31, 2016 June 30, 2016 December 31, 2016 June 30, 2016 December 31, 2016 December 31, 2015 United States $ 10,897 $ 9,678 $ 46,424 $ 49,755 $ 1,812 $ 320 Europe 6,572 5,489 26,370 24,420 1,550 1,090 $ 17,469 $ 15,167 $ 72,794 $ 74,175 $ 3,362 $ 1,410

Note A - Basis of Presentatio24

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) - USD ($) xbrli-pure in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Jun. 30, 2016
Royalty and Licensing Revenue	$ 6,700,000	$ 5,300,000	$ 13,400,000	$ 10,600,000
Royalty Expense	250,000	209,000	566,000	473,000
Allocated Share-based Compensation Expense	256,000	$ 150,000	506,000	$ 280,000
Fair Value, Inputs, Level 1 [Member]
Fair Value, Net Asset (Liability)	0		0		$ 0
Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Forward [Member]
Foreign Currency Contract, Asset, Fair Value Disclosure	2,000,000		2,000,000		250,000
Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Asset (Liability)	$ 0		$ 0		$ 0
2009 Omnibus Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate			0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0	0	0	0
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	100,000	0	100,000

Note A - Basis of Presentatio25

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Numerator
Net Income	$ 2,466	$ 1,868	$ 4,956	$ 3,081
Denominator
Basic weighted average common shares outstanding (in shares)	6,567,468	6,509,893	6,562,932	6,515,280
Dilutive effect of stock options (in shares)	116,000	119,000	102,000	147,000
Diluted weighted average common shares outstanding (in shares)	6,683,356	6,628,752	6,665,159	6,662,036
Basic net income per common share (in dollars per share)	$ 0.38	$ 0.29	$ 0.76	$ 0.47
Diluted net income per common share (in dollars per share)	$ 0.37	$ 0.28	$ 0.74	$ 0.46

Note B - Inventories, Net - Sum

Note B - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Raw materials	$ 11,475	$ 14,751
Work in progress	2,096	3,487
Finished goods	3,836	2,832
Reserves	(340)	(302)
Inventories, net	$ 17,067	$ 20,768

Note C - Property and Equipme27

Note C - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Jun. 30, 2016
Property and equipment, gross	$ 49,806	$ 46,834
Less: accumulated depreciation and amortization	(32,337)	(31,667)
Property and equipment, net	17,469	15,167
Land [Member]
Property and equipment, gross	1,200	1,200
Building and Building Improvements [Member]
Property and equipment, gross	$ 3,616	3,324
Building and Building Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	7 years
Building and Building Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	39 years
Machinery and Equipment [Member]
Property and equipment, gross	$ 24,772	23,846
Machinery and Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Machinery and Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	12 years
Office Equipment [Member]
Property and equipment, gross	$ 3,577	2,994
Office Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Office Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	5 years
Vehicles [Member]
Property and equipment, gross	$ 209	209
Depreciable Life In Years (Year)	3 years
Vehicles [Member] | Maximum [Member]
Depreciable Life In Years (Year)	3 years
Leasehold Improvements [Member]
Property and equipment, gross	$ 16,432	$ 15,261
Leasehold Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	1 year
Leasehold Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	15 years

Note D - Accumulated Other Co28

Note D - Accumulated Other Comprehensive (Loss) Income (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Revenue, Net	$ 30,559,000	$ 26,911,000	$ 64,626,000	$ 48,496,000
Other Nonoperating Income (Expense)	(8,000)	(2,000)	(15,000)	(10,000)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]
Revenue, Net	213,000	45,000	271,000	7,000
Other Nonoperating Income (Expense)	$ 130,000	$ 24,000	$ 230,000	$ 51,000

Note D - Accumulated Other Co29

Note D - Accumulated Other Comprehensive (Loss) Income - Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Beginning balance			$ 53,726
Ending balance	$ 59,956		59,956
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Beginning balance	(775)	$ (643)	(775)	$ (643)
OCI/OCL before reclassifications
Amounts Reclassified from OCI
Tax Effect of OCI Activity
Net current period OCI/OCL
Ending balance	(775)	(643)	(775)	(643)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Beginning balance	(295)	(79)	95	(123)
OCI/OCL before reclassifications	2,287	424	1,834	482
Amounts Reclassified from OCI	(343)	(69)	(501)	(58)
Tax Effect of OCI Activity	(702)	(125)	(481)	(150)
Net current period OCI/OCL	1,242	230	852	274
Ending balance	947	151	947	151
AOCI Attributable to Parent [Member]
Beginning balance	(1,070)	(722)	(680)	(766)
OCI/OCL before reclassifications	2,287	424	1,834	482
Amounts Reclassified from OCI	(343)	(69)	(501)	(58)
Tax Effect of OCI Activity	(702)	(125)	(481)	(150)
Net current period OCI/OCL	1,242	230	852	274
Ending balance	$ 172	$ (492)	$ 172	$ (492)

Note E - Debt (Details Textual)

Note E - Debt (Details Textual)	Feb. 01, 2016USD ($)	Dec. 31, 2016USD ($)	Nov. 30, 2016USD ($)	Nov. 30, 2016CHF (SFr)	Jan. 31, 2016USD ($)
Line of Credit Facility, Remaining Borrowing Capacity		$ 10,000,000
Proceeds from Long-term Lines of Credit		0
Long-term Debt		0
Natural Alternatives International Europe SA [Member]
Line of Credit Facility Maximum Amount Outstanding after Reduction			$ 488,000	SFr 500,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 10,000,000				$ 5,000,000
Long-term Debt, Percentage Bearing Fluctuating Interest, Threshold Amount	100,000
Minimum Prepayment Amount Under Line of Credit	100,000
Long-term Line of Credit		$ 0
Line of Credit Facility, Commitment Fee Amount	$ 0
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.25%
Debt Instrument Basis Spread on Elected Fixed Rate Borrowing	1.25%
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Maximum [Member]
Ratio of Indebtedness to Net Capital	1.25
Ratio of Total Current Assets to Total Current Liabilities	1.75

Note F - Economic Dependency -

Note F - Economic Dependency - Substantial Net Sales to Certain Customers (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2016		Dec. 31, 2015	Dec. 31, 2016		Dec. 31, 2015
Revenue, Net	$ 30,559		$ 26,911	$ 64,626		$ 48,496
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member]
Revenue, Net	15,074		15,206	32,152		25,030
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member] | Customer 1 [Member]
Revenue, Net	15,074		11,902	32,152		18,691
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member] | Customer 2 [Member]
Revenue, Net		[1]	$ 3,304		[1]	$ 6,339
[1]	Sales were less than 10% of the respective period's total revenues.

Note F - Economic Dependency 32

Note F - Economic Dependency - Substantial Net Purchase From Certain Supplier (Details) - Supplier Concentration Risk [Member] - Raw Material Purchases [Member] - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Dec. 31, 2016		Dec. 31, 2015		Dec. 31, 2016		Dec. 31, 2015
Raw Material Purchases by Supplier			$ 1,395				$ 3,097
% of Total Raw Material Purchases			12.00%				12.00%
Supplier 1 [Member]
Raw Material Purchases by Supplier		[1]		[1]		[1]	$ 3,097
% of Total Raw Material Purchases							12.00%
Supplier 2 [Member]
Raw Material Purchases by Supplier		[1]	$ 1,395			[1]		[1]
% of Total Raw Material Purchases			12.00%
[1]	Purchases were less than 10% of the respective period's total raw material purchases.

Note G - Segment Information (D

Note G - Segment Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Number of Reportable Segments			2
Revenue, Net	$ 30,559	$ 26,911	$ 64,626	$ 48,496
Non-US [Member]
Revenue, Net	16,905	14,413	35,747	23,205
UNITED STATES
Revenue, Net	$ 13,654	$ 12,498	$ 28,879	$ 25,291
Products Manufactured by NAIE [Member] | Non-US [Member] | Sales Revenue, Net [Member] | Product Concentration Risk [Member]
Concentration Risk, Percentage	60.00%	71.00%	53.00%	74.00%
Products Manufactured by NAIE [Member] | UNITED STATES
Revenue, Net	$ 0	$ 0	$ 0	$ 0

Note G - Segment Information -

Note G - Segment Information - Operating Results by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Revenue, Net	$ 30,559	$ 26,911	$ 64,626	$ 48,496
Income from Operations
Income from Operations	3,113	2,735	6,649	4,463
Operating Segments [Member]
Income from Operations
Income from Operations	4,488	4,235	9,702	7,294
Corporate, Non-Segment [Member]
Income from Operations
Income from Operations	(1,375)	(1,500)	(3,053)	(2,831)
Private Label Contract Manufacturing [Member]
Revenue, Net	23,864	21,619	51,243	37,884
Private Label Contract Manufacturing [Member] | Operating Segments [Member]
Income from Operations
Income from Operations	2,148	2,543	5,462	4,603
Patent and Trademark Licensing [Member]
Revenue, Net	6,695	5,292	13,383	10,612
Patent and Trademark Licensing [Member] | Operating Segments [Member]
Income from Operations
Income from Operations	$ 2,340	$ 1,692	$ 4,240	$ 2,691

Note G - Segment Information 35

Note G - Segment Information - Assets by Business Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Jun. 30, 2016
Assets	$ 72,794	$ 74,175
Private Label Contract Manufacturing [Member]
Assets	62,742	66,375
Patent and Trademark Licensing [Member]
Assets	$ 10,052	$ 7,800

Note G - Segment Information 36

Note G - Segment Information - Net Sales by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Revenue, Net	$ 30,559	$ 26,911	$ 64,626	$ 48,496
UNITED STATES
Revenue, Net	13,654	12,498	28,879	25,291
Non-US [Member]
Revenue, Net	$ 16,905	$ 14,413	$ 35,747	$ 23,205

Note G - Segment Information 37

Note G - Segment Information - Assets and Capital Expenditures by Geographical Region (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Jun. 30, 2016
Long-Lived Assets	$ 17,469		$ 15,167
Assets	72,794		74,175
Capital Expenditures	3,362	$ 1,410
UNITED STATES
Long-Lived Assets	10,897		9,678
Assets	46,424		49,755
Capital Expenditures	1,812	320
Europe [Member]
Long-Lived Assets	6,572		5,489
Assets	26,370		$ 24,420
Capital Expenditures	$ 1,550	$ 1,090

Note H - Income Taxes (Details

Note H - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2016
Effective Income Tax Rate Reconciliation, Percent	29.60%	30.10%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount		$ 0
Unrecognized Tax Benefits, Period Increase (Decrease)		$ 0
Earliest Tax Year [Member] | Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Open Tax Year		2,013
Earliest Tax Year [Member] | State and Local Jurisdiction [Member]
Open Tax Year		2,008

Note I - Treasury Stock (Detail

Note I - Treasury Stock (Details Textual) - USD ($)	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	May 11, 2015	Feb. 06, 2015	Jun. 02, 2011
Stock Repurchase Program, Authorized Amount			$ 5,000,000	$ 3,000,000	$ 2,000,000
Treasury Stock, Shares, Acquired	0	35,703
Treasury Stock Acquired, Average Cost Per Share		$ 5.91
Treasury Stock, Value, Acquired, Cost Method		$ 212,000
2015 Increase [Member]
Stock Repurchase Program, Authorized Amount			$ 2,000,000	$ 1,000,000

Note J - Derivatives and Hedg40

Note J - Derivatives and Hedging (Details Textual) € in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2016EUR (€)	Jun. 30, 2016USD ($)
Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net	$ 92,000	$ 0	$ 92,000	$ 0
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	1,500,000		1,500,000
Cash Flow Hedging [Member]
Derivative Instruments, Gain Recognized in Other Comprehensive Income (Loss), Effective Portion	2,300,000	424,000	1,800,000	482,000
Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion	213,000	$ 45,000	271,000	$ 7,000
Prepaid Expenses and Other Current Assets [Member]
Cash Flow Hedge Derivative Instrument Assets at Fair Value	2,000,000		2,000,000			$ 226,000
Reclassification out of Accumulated Other Comprehensive Income [Member]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	1,300,000		1,300,000
Cash Flow Hedging Foreign Exchange Contract [Member]
Derivative, Notional Amount	$ 35,200,000		$ 35,200,000		€ 31.1